Allstate Corporation’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.64M | Sell |
15,857
-980
| -6% | -$322K | 0.05% | 252 |
|
|
2025
Q4 | $5.9M | Buy |
16,837
+8,445
| +101% | +$2.85M | 0.08% | 154 |
|
|
2025
Q3 | $2.71M | Buy |
8,392
+7,860
| +1,477% | +$2.44M | 0.06% | 174 |
|
|
2025
Q2 | $207K | Sell |
532
-7,157
| -93% | -$2.88M | 0.01% | 171 |
|
|
2025
Q1 | $3.34M | Buy |
7,689
+762
| +11% | +$306K | 0.1% | 131 |
|
|
2024
Q4 | $2.56M | Buy |
+6,927
| New | +$2.9M | 0.08% | 138 |
|
|
2024
Q3 | – | Sell |
-864
| Closed | -$468K | – | 149 |
|
|
2024
Q2 | $468K | Hold |
864
| – | – | 0.04% | 121 |
|
|
2024
Q1 | $448K | Sell |
864
-9
| -1% | -$4.48K | 0.03% | 124 |
|
|
2023
Q4 | $412K | Sell |
873
-46
| -5% | -$21.3K | 0.03% | 123 |
|
|
2023
Q3 | $400K | Hold |
919
| – | – | 0.02% | 121 |
|
|
2023
Q2 | $408K | Sell |
919
-17
| -2% | -$7.84K | 0.03% | 128 |
|
|
2023
Q1 | $430K | Sell |
936
-9,497
| -91% | -$4.52M | 0.03% | 117 |
|
|
2022
Q4 | $5.35M | Buy |
10,433
+81
| +0.8% | +$41.1K | 0.16% | 88 |
|
|
2022
Q3 | $4.7M | Sell |
10,352
-101
| -1% | -$48.3K | 0.14% | 86 |
|
|
2022
Q2 | $5.04M | Sell |
10,453
-1,300
| -11% | -$643K | 0.16% | 92 |
|
|
2022
Q1 | $5.77M | Sell |
11,753
-8,448
| -42% | -$3.86M | 0.15% | 92 |
|
|
2021
Q4 | $9.36M | Buy |
20,201
+14,327
| +244% | +$6.03M | 0.18% | 90 |
|
|
2021
Q3 | $2.19M | Sell |
5,874
-536
| -8% | -$204K | 0.09% | 116 |
|
|
2021
Q2 | $2.45M | Sell |
6,410
-476
| -7% | -$182K | 0.08% | 103 |
|
|
2021
Q1 | $2.47M | Buy |
6,886
+868
| +14% | +$279K | 0.08% | 112 |
|
|
2020
Q4 | $1.93M | Sell |
6,018
-506
| -8% | -$155K | 0.06% | 136 |
|
|
2020
Q3 | $1.75M | Sell |
6,524
-1,315
| -17% | -$354K | 0.06% | 126 |
|
|
2020
Q2 | $2.06M | Sell |
7,839
-1,669
| -18% | -$445K | 0.07% | 113 |
|
|
2020
Q1 | $2.16M | Sell |
9,508
-4,251
| -31% | -$1.16M | 0.08% | 100 |
|
|
2019
Q4 | $4.16M | Sell |
13,759
-13
| -0.1% | -$3.58K | 0.08% | 170 |
|
|
2019
Q3 | $3.31M | Sell |
13,772
-9,302
| -40% | -$2.55M | 0.06% | 199 |
|
|
2019
Q2 | $6.51M | Buy |
23,074
+9,425
| +69% | +$2.57M | 0.12% | 91 |
|
|
2019
Q1 | $3.92M | Sell |
13,649
-3,907
| -22% | -$1.13M | 0.11% | 137 |
|
|
2018
Q4 | $4.61M | Buy |
+17,556
| New | +$4.83M | 0.15% | 98 |
|
|
2017
Q3 | – | Sell |
-7,719
| Closed | -$1.45M | – | 103 |
|
|
2017
Q2 | $1.45M | Buy |
+7,719
| New | +$1.39M | 0.08% | 130 |
|
|
2017
Q1 | – | Sell |
-26,857
| Closed | -$3.86M | – | 201 |
|
|
2016
Q4 | $3.86M | Buy |
26,857
+15,742
| +142% | +$2.11M | 0.23% | 129 |
|
|
2016
Q3 | $1.39M | Buy |
11,115
+8,505
| +326% | +$1.1M | 0.1% | 135 |
|
|
2016
Q2 | $343K | Buy |
+2,610
| New | +$357K | 0.02% | 158 |
|
|
2015
Q4 | – | Sell |
-18,038
| Closed | -$2.52M | – | 184 |
|
|
2015
Q3 | $2.52M | Buy |
18,038
+2,607
| +17% | +$392K | 0.26% | 116 |
|
|
2015
Q2 | $2.53M | Sell |
15,431
-1,825
| -11% | -$292K | 0.23% | 96 |
|
|
2015
Q1 | $2.66M | Buy |
+17,256
| New | +$2.46M | 0.22% | 138 |
|
Other funds holding ELV
VCM
VPM
Allstate Corporation's ELV Position: Q1 2026 in Review
Allstate Corporation reduced its Elevance Health (ELV) stake by 5.8% in Q1 2026, selling an estimated $322K and leaving 15,857 shares worth $4.64M. The position accounts for 0.05% of the portfolio, ranked #252.
Allstate Corporation first reported a position in ELV in Q1 2015 and has held it in 36 quarters since. The position peaked at $9.36M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Allstate Corporation held 15,857 shares of Elevance Health worth $4.64M as of Q1 2026.
- Allstate Corporation sold 980 Elevance Health shares in Q1 2026, an estimated $322K.
- Elevance Health made up 0.05% of Allstate Corporation's portfolio in Q1 2026, its #252 holding.
- Allstate Corporation first reported a position in Elevance Health in Q1 2015 and has held it in 36 quarters since.
- Allstate Corporation's Elevance Health position peaked at $9.36M in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.